InfuSystem Holdings (INFU) Cost of Revenue (2010 - 2026)

InfuSystem Holdings' Cost of Revenue history runs 17 years deep, the most recent figure standing at $14.0 million for Q1 2026.

• Quarterly Cost of Revenue fell 9.95% year-over-year to $14.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $61.6 million (down 4.49% YoY) and the FY2025 annual result came in at $63.1 million, down 2.04% from the prior year.
• Cost of Revenue was $14.0 million for Q1 2026 at InfuSystem Holdings, down from $15.8 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $17.0 million in Q2 2024 and bottomed at $11.1 million in Q3 2022.
• A 5-year average of $14.9 million and a median of $15.5 million in 2025 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue soared 47.31% — and 2026, when it declined 9.95%.
• InfuSystem Holdings' Cost of Revenue stood at $14.8 million in 2022, then advanced by 2.05% to $15.1 million in 2023, then increased by 3.8% to $15.6 million in 2024, then increased by 1.04% to $15.8 million in 2025, then retreated by 11.35% to $14.0 million in 2026.
• Business Quant data shows INFU's Cost of Revenue at $14.0 million in Q1 2026, $15.8 million in Q4 2025, and $15.7 million in Q3 2025.